Skip to main content

Table 2 Identification of PGs and harvest of lymph nodes in CN group versus control group

From: Evaluation of the clinical value of carbon nanoparticles in endoscopic thyroidectomy and prophylactic central neck dissection through total mammary areolas approach for thyroid cancer

Variables

CN

Control

p value

Numbers of identified PGs

Superior PGs (not identified)

5/69

8/92

0.512

Inferior PGs

42/69

54/92

0.361

Numbers of harvested LNs (mean ± SD)

   

 LNs > 5mm

1.81 ± 1.30

2.03 ± 1.24

0.354

 LNs < 5 mm

3.83 ± 1.50

2.00 ±1.18

< 0.001*

 Total LNs

5.65 ± 2.62

4.06 ± 2.48

0.001*

Numbers of patients with metastatic LN

11

15

0.565

Numbers of metastatic LN**

 LN > 5mm

18

25

-

 LN < 5 mm

3

2

-

  1. PGs parathyroid glands, CN carbon nanoparticles, LNs lymph nodes
  2. *p < 0.05
  3. **In some cases, there were more than one metastatic LN